期刊文献+

腹腔内热灌注化疗预防进展期胃癌术后腹腔复发的临床研究 被引量:3

Clinical Study on the Reccrrrence of Peritoneal Cavity with Hyrerthemic Peritoneal Perfusion after Gastric Cancer
暂未订购
导出
摘要 目的 :评价腹腔内热灌注化疗对侵及浆膜的进展癌根治术后预防腹腔复发的疗效。方法 :1994年 12月~ 1996年 12月 96例可切除的进展期胃癌患者随机分成治疗组和对照组。治疗组 52例应用DDP 80mg +MMC 10mg +5 FU 1.0加入生理盐水 ( 0 .9% ) 150 0ml加热至 4 3℃ ,进行腹腔灌注 ,连用 4~ 6周。对照组 4 4例常规给予口服优福定。结果 :治疗组和对照组 3年生存率分别为 61.5%、4 5.5%(P <0 .0 1) ,腹腔复发率分别为 5.2 %、30 % (P <0 .0 1)。结论 :腹腔热灌注化疗可以预防侵犯浆膜的进展期胃癌术后腹腔复发 ,是一种安全。 Objective:To evaluate the effect of preventing the recurrence of peritoneal cavity with hyperthemic peritoneal prerfusion after resection of gastic canecer which had penetrated the serosa and visceral peritoneum.Methods:From December 1994 to December 1996.96 cases were devised into treatment group(groip 1)and control group (group2).52 cases(group1) were treated with hyrerthemic peritoneal prerfusion after resection of adrvace gastic cancer.DDP 80 mg and 5 FU 1.0 and MMe 10 mg in 1500 ml 0.9% sodinm chloride the thermometer 43℃were intrdperictoneally in jected erery week for 4 to 6 times,44cases(groupⅡ)as control were used to take tablets of UFT.Results:The 3-year survival rate in group Ⅰand gronp Ⅱwere 61 5%,45 5%( P <0 01) The recurrence of peritoneal cavity in group Ⅰand gronp Ⅱwere 5 2%,30%( P <0 01).Conclusions:This is a safe and effective methad for preoenting the recurrence of peritoneal cavity after resection of invading serosa from advanced gastric cancer.
出处 《肿瘤防治杂志》 2000年第3期261-262,共2页 China Journal of Cancer Prevention and Treatment
关键词 腹腔内热灌注化疗 胃肿瘤 预防 hyrerthemic preitoneal perfusion stomach neoplasms
  • 相关文献

参考文献5

二级参考文献4

  • 1陈峻青,王梅先,齐春莲,王舒宝,单吉贤,张文范,张荫昌.胃癌淋巴结转移及其分型的病理生物学意义[J].实用外科杂志,1989,9(9):478-480. 被引量:24
  • 2徐光炜,胃癌,1987年,82页
  • 3Dr. Akio Yamaguchi M. D.,Yuuji Tsukioka M. D.,Sachio Fushida M. D.,Yoshiyuki Kurosaka M. D.,Masahiro Kanno M. D.,Yutaka Yonemura M. D.,Kouichi Miwa M.D.,Itsuo Miyazaki M. D.. Intraperitoneal hyperthermic treatment for peritoneal dissemination of colorectal cancers[J] 1992,Diseases of the Colon &amp; Rectum(10):964~968
  • 4Qinghua Liu,Junqing Chen. The relationship between serosal types, pathological characteristics and free cancer cells in the peritoneal cavity of gastric cancer patients[J] 1989,Chinese Journal of Cancer Research(3):58~61

共引文献154

同被引文献18

  • 1张竝,姜朝晖,方旭东,洪宇.胃癌患者术中腹腔低渗热灌注化疗的长期预后观察[J].中华胃肠外科杂志,2004,7(4):289-291. 被引量:16
  • 2Sugarbaker P Ⅱ. Rationale for early postoperative intraperitoneal chemotherapy as a surgical adjuvant for gastrointestinal malignancy. Regul Cancer Treat, 1989; 1:66
  • 3Osker AG. A rationale for carboplatin treatment and abdominal hyperthemia in cancers resticted to peritoneal cavity. Cancer Res, 1992;52:1252
  • 4Iiamazoe R, Matea M, Kaihara N. Intraperitoneal thermochemotherapy for prevention of peritoneal recurrence of gastric cancer: final results of arandomized controlled study. Cancer, 1994; 73(8) :2048
  • 5Fujimura T, Yonemura Y, Muraoka K, et al. Continuous hyperthermic peritoneal peffusion for the prevention of peritoneal recurrence of gastric cancer: randomized controlled study. World J Surg, 1994; 18:150- 155
  • 6Tubiana M: Scientific Foundation of Oncology; Edited by Symington T and Cart RL, 1976;126- 136
  • 7Sugarbaker PⅡ . Semin oncol, 1989; 16:83 - 97
  • 8Fujimoto S. Tokahashi M, Kokayashi K. Cytohistologic assessment of antiumor effects of imraperitoneal with mitomycin C for patients oicth gastric cancer with peritoneal metastasis. Cancer, 1992;70:2754
  • 9Japanese Gastric Cancer Association: Japanese classification of gastric carcinoma - 2 nd English Edition[J]. Br J Surg, 2000;87(8): 1006 -1015
  • 10李鼎九 张珊文.哺乳类动物细胞加温后细胞及分子水平[A].见李鼎九 胡自省 钟毓斌.肿瘤热疗学 (第二版)[C].郑州大学出版社,2003.25-34.

引证文献3

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部